Shandong, China, May 14, 2025 — Wixbio today announced the successful shipment of another large-scale order for the Turkish market, totaling 10,500 500 500 ml vials of the triple custom inactivated vaccine against Newcastle Disease (ND), Avian Influenza (AI H9 subtype), and Duck Adenovirus (FADV). This shipment not only reflects the high level of customer trust in Wixbio’s products but also signifies the product’s continued success in the Turkish market and favorable market feedback.
The vaccines are tailored to the specific needs of the Turkish customer. They are designed to help the local farming industry effectively prevent and control these diseases that seriously affect poultry health. Newcastle disease, avian influenza subtype H9, and duck adenovirus cause serious health problems in poultry, reducing productivity and resulting in significant economic losses. This triple vaccine is therefore essential for safeguarding poultry health and improving farm efficiency.
Given the customer’s multiple repurchases and the positive feedback from the market, this shows that the quality and effectiveness of Wixbio’s products are well recognized. To ensure the vaccine’s activity and efficacy during transportation, all products are packaged according to strict cold chain management standards to ensure they reach their destination at the highest quality.
This shipment further strengthens Wixbio’s relationship with its Turkish customer and demonstrates its global animal health leadership. By providing efficient and safe solutions, Wixbio supports the growth of the Turkish farming industry and sets an example for its partners in other regions.
Wixbio is a company specializing in the development, production, and marketing of veterinary drugs and animal vaccines. With advanced technology and high-quality products, the company provides strong support to the livestock industry globally. Wixbio always adheres to the customer’s needs and continuously promotes technological innovation, aiming to be the leading animal health partner in the world.
